InvestorsHub Logo
Followers 1106
Posts 279775
Boards Moderated 10
Alias Born 03/18/2011

Re: None

Wednesday, 02/25/2015 9:54:45 AM

Wednesday, February 25, 2015 9:54:45 AM

Post# of 17485
$PMCB ~ PharmaCyte Biotech, Inc. (PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box(R), announced today that Dr. Matthius Lohr, Chairman of its Scientific Advisory Board, together with his colleagues Dr. Verbeke, Dr. Severin Karlsson and Dr. Del Charro from the Karolinska Institute in Stockholm, Sweden, have published a medical and scientific review article that is directed to improving the treatment of pancreatic cancer.




Websites: ~ http://www.PharmaCyteBiotech.com ~
News: http://finance.yahoo.com/q/h?s=PMCB+Headlines
Live Chart: http://stockcharts.com/c-sc/sc?s=PMCB&p=D&b=6&g=0&i=p48221558137



Do your DD! Spend only the money you can afford to lose, while still willing to play at other tables. Commissions are cheaper than losses!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.